- Colorectal cancer is the second leading cause of cancer death in the United States and Canada.
- One out of 18 people in the United States will develop colorectal cancer in their lifetime.
- Colorectal cancer is the third most diagnosed cancer in the United States and Canada.
- Colorectal cancer is preventable if a polyp is removed before it turns into cancer.
The blue star symbol signifies the united effort in the battle to prevent colorectal cancer deaths. The symbol is a star, representing the eternal memory of those people whose lives have already been lost to the disease and the shining hope for a future free of colon cancer. The star is merged with the more common ribbon for awareness and assumes a human shape.
The Cause
The American Cancer Society estimates that there will be 153,760 new cases of colorectal cancer diagnosed in the U.S. in 2007. That means a person in the U.S. is diagnosed with colorectal cancer every 4 minutes.
A personal or family history of colon and/or rectum cancer or polyps and inflammatory bowel disease have been associated with an increased risk for this type of cancer. Other risk factors include physical inactivity, high-fat and/or low-fiber diet, and an inadequate intake of fruits and vegetables.
Colorectal cancer is preventable if a polyp is removed before it turns into cancer. The best way to prevent colorectal cancer is to get screened by having a colonoscopy. Furthermore, colorectal cancer is treatable and beatable if it's caught in its' early stages.
Our Beneficiary
The collaborative efforts of the clinicians and researchers at Johns Hopkins Sidney Kimmel Cancer Center have led to many advances in the early detection and treatment of colon and rectal cancer. These endeavors promise to translate into better treatment outcomes for all patients.
With your sponsorship in the 2007 immixGroup Charity Golf Tournament, funding will be utilized to support the education of patients with colorectal cancer as well as outreach and awareness focused on screening and prevention of colorectal cancer. Contributions will also be used to further a colon cancer research initiative under the direction of Dr. Michael Choti, M.D., Director of the Johns Hopkins Colon Cancer Center.
For more information about colorectal cancer, including statistics, diagnosis and treatment, visit: